Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jun 01, 2009 (Vol. 29, No. 11)

e.hormone

URL:e.hormone.tulane.edu
  • Good organization, quality of information
  • None
This sounds like it could be the next in a long line of online dating sites, skipping the romance and frills and going straight for the biochemistry. (Why choose eHarmony, when you can attack love at its physiological core?) Well, don’t get too excited. This website is a very enticing page, but not because of any personal profile. Instead, it proclaims itself as “…your gateway to the environment and hormones…” Indeed, the homepage is a gateway to a plethora of information about the endocrine system, specific hormones, endocrine disrupting signals, and more. Hosted by the Center for Bioenvironmental Research at Tulane/Xavier Universities, this website is nicely organized and up to date with conference information and news of interest to the field of environmental signaling. Whether you’re in the trenches of endocrinology research, or simply wondering what a phytoestrogen is, the information on this site should sate your hormonal hunger.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »